V Square Quantitative Management LLC Buys 1,264 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

V Square Quantitative Management LLC boosted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 31.0% in the 3rd quarter, Holdings Channel.com reports. The firm owned 5,346 shares of the healthcare conglomerate’s stock after purchasing an additional 1,264 shares during the quarter. V Square Quantitative Management LLC’s holdings in UnitedHealth Group were worth $3,126,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently added to or reduced their stakes in UNH. Czech National Bank raised its holdings in UnitedHealth Group by 0.4% in the 1st quarter. Czech National Bank now owns 162,741 shares of the healthcare conglomerate’s stock valued at $80,508,000 after acquiring an additional 719 shares in the last quarter. Bruce G. Allen Investments LLC increased its holdings in UnitedHealth Group by 6.6% during the 1st quarter. Bruce G. Allen Investments LLC now owns 938 shares of the healthcare conglomerate’s stock valued at $464,000 after purchasing an additional 58 shares in the last quarter. Legacy Private Trust Co. increased its holdings in UnitedHealth Group by 6.3% during the 1st quarter. Legacy Private Trust Co. now owns 10,174 shares of the healthcare conglomerate’s stock valued at $5,033,000 after purchasing an additional 604 shares in the last quarter. First National Bank of Mount Dora Trust Investment Services boosted its position in UnitedHealth Group by 0.7% in the 1st quarter. First National Bank of Mount Dora Trust Investment Services now owns 9,892 shares of the healthcare conglomerate’s stock valued at $4,894,000 after buying an additional 67 shares during the last quarter. Finally, Grassi Investment Management boosted its position in UnitedHealth Group by 39.5% in the 1st quarter. Grassi Investment Management now owns 1,235 shares of the healthcare conglomerate’s stock valued at $611,000 after buying an additional 350 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have commented on UNH shares. Truist Financial reiterated a “buy” rating and issued a $625.00 price objective (down from $640.00) on shares of UnitedHealth Group in a research report on Wednesday. Jefferies Financial Group upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and raised their price target for the stock from $481.00 to $647.00 in a research report on Wednesday, July 17th. Bank of America reduced their price target on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research report on Wednesday. Barclays lifted their target price on UnitedHealth Group from $560.00 to $604.00 and gave the stock an “overweight” rating in a report on Wednesday, July 17th. Finally, StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Wednesday. Two research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Buy” and an average target price of $615.16.

UnitedHealth Group Stock Up 0.4 %

Shares of NYSE:UNH traded up $2.18 during midday trading on Friday, reaching $568.21. The company had a trading volume of 828,856 shares, compared to its average volume of 3,951,675. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $608.63. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67. The stock has a market cap of $524.70 billion, a PE ratio of 37.53, a P/E/G ratio of 1.69 and a beta of 0.58. The business’s 50 day moving average price is $584.20 and its 200 day moving average price is $533.07.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The business had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. During the same quarter last year, the company posted $6.56 earnings per share. UnitedHealth Group’s quarterly revenue was up 9.2% on a year-over-year basis. Research analysts forecast that UnitedHealth Group Incorporated will post 27.68 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.48%. The ex-dividend date was Monday, September 16th. UnitedHealth Group’s dividend payout ratio is presently 55.70%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.